Kate Madden Yee[email protected]Bacterial VaginosisUSPSTF: Pregnant women may not need vaginosis screeningThe recommendation updates the task force's 2008 guideline with a further literature review but is not different, wrote a team led by USPSTF chair Dr. Douglas Owens of Stanford University. The group found that bacterial vaginosis screening just doesn't seem to offer an advantage for avoiding preterm delivery, which has been associated with the condition.April 7, 2020COVID-19Testing confirms bathhouse transmission of SARS-CoV-2The findings are in contrast to the general assumption that transmission of the virus is undermined in humid, high-temperature environments, wrote a team led by Dr. Chao Luo, PhD, of Nanjing Medical University in Huai'an, China.April 1, 2020Immune System DiseasesDo patients still have COVID-19 after symptoms resolve?Researchers found that patients treated for mild COVID-19 still had the virus for up to eight days after symptoms resolved -- a result that underscores the difficulty of curbing the disease.March 29, 2020Diagnostic TechnologiesPediatric bilirubin screening could avert transplantsThe study results offer parents and their newborns a better way to treat the disease, wrote a team led by Dr. Sanjiv Harpavat, PhD, an assistant professor of pediatrics-gastroenterology at Baylor College of Medicine.March 24, 2020Health TopicsStudies find that coronavirus transmits before symptomsA team of researchers led by Dr. Zhanwei Du of the University of Texas in Austin found that that "time between cases in a chain of transmission is less than a week and that more than 10% of patients are infected by somebody who has the virus but does not yet have symptoms," the university said in a statement.March 16, 2020Health TopicsGottlieb: More coronavirus kits coming, but so is crisisIn fact, the U.S. is just at the beginning of an epidemic spread of the virus, Gottlieb said.March 15, 2020Health TopicsASM: Reagent shortages threaten coronavirus test access"We are deeply concerned that as the number of tests increases dramatically over the coming weeks, clinical labs will be unable to deploy them without these critical components," the ASM said. "Increased demand for testing has the potential to exhaust supplies needed to perform the testing itself. This could include chemicals or plastics, for example, and could affect tests developed and offered by clinical or public health laboratories and/or (when they become available in the United States), commercial tests."March 12, 2020Immune System DiseasesBlood marker may predict kidney transplant failure riskThe results could help clinicians better intervene before patients experience transplant rejection, wrote corresponding author Nicolas Degauque, PhD, of the Université de Nantes, France, and colleagues.March 12, 2020Health TopicsStudy outlines 1st person-to-person coronavirus spreadThe report highlights that those living with or providing care for people with symptomatic coronavirus are at risk, noted study co-author Dr. Tristan McPherson of the Chicago Department of Public Health.March 11, 2020InfectiousBlood test shows promise for identifying cancerThe findings point to important shifts in the field of cancer biology, said lead author and MD/PhD student Gregory Poore, of the University of California, San Diego (UCSD), in a statement. Poore is pursuing his graduate work in the laboratory of Rob Knight, PhD, at UCSD's Center for Microbiome Innovation.March 11, 2020Previous PagePage 3 of 4Next PageTop StoriesGene silencing and gene editingEngineered Cas clears barrier to antiviral CRISPR therapiesResearchers have engineered a Cas enzyme to enhance activity against RNA viruses, resulting in a system that completely blocked the replication of various SARS-CoV-2 strains.Artificial IntelligenceAI-powered endoscope doubles detection of high-risk esophageal lesionsMergers & AcquisitionsBruker to acquire NanoString for $392.6MTrends and FinanceDermTech receives delisting warning from NasdaqSponsor ContentVisit our Molecular Diagnostics Community